Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Alzamend Neuro, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 27 | 16 | −11 |
| SharesConverted for a 1-for-15 split | 420.3K | 374.4K | −46.0K (−10.9%) |
| Value | $1.49M | $334.7K | −$1.16M (−77.6%) |
New holders (4)
Institutions that held Alzamend Neuro, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 16,806 | $15.0K | 0.00% |
| Baystate Wealth Management LLC | 66 | $59 | 0.00% |
| Bank of America Corp | 47 | $42 | 0.00% |
| Parallel Advisors, LLC | 33 | $29 | 0.00% |
Sold out (15)
Institutions that held Alzamend Neuro, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Northern Trust Corp | 103,775 | $24.6K |
| Charles Schwab Investment Management Inc | 53,080 | $12.6K |
| Bank of New York Mellon Corp | 40,367 | $9.57K |
| Integrated Investment Consultants, LLC | 40,000 | $9.48K |
| State Street Corp | 31,900 | $7.56K |
| Two Sigma Securities, LLC | 28,156 | $6.67K |
| Millennium Management LLC | 27,629 | $6.55K |
| Foundations Investment Advisors, LLC | 20,000 | $4.74K |
| Commonwealth Equity Services, LLC | 16,666 | $4.00K |
| XTX Topco Ltd | 12,974 | $3.08K |
| Insight Wealth Strategies, LLC | 10,000 | $2.37K |
| IFP Advisors, Inc | 5,000 | $1.19K |
| FMR LLC | 268 | $64 |
| JPMorgan Chase & Co | 49 | $12 |
| Simplex Trading, LLC | 79 | $0 |